Search results
Author(s):
Enoch Akowuah
Added:
1 year ago
ACC.23/WCC—DrEnoch Akowuah (James Cook University Hospital, UK) joins us to share the findings of the UK Mini-Mitral trial (National Institute of Health Research).
This study is a multicentre, expertise-based randomised controlled trial that aimed to compare the safety and effectiveness of a minimally-invasive thoracotomy compared to conventional sternotomy in treating patients with degenerative…
View more
Author(s):
Frederic Baumann
,
Nicolas Diehm
Added:
3 years ago
Chronic critical limb ischaemia (CLI) affects a defined subgroup of patients with systemic atherosclerosis. Often, these patients exhibit additional cardiovascular risk factors and co-morbidities, which complicate their disease pattern and limit treatment modalities. Therefore, CLI is clearly associated with excessive morbidity and mortality rates and leads to a substantial decline in quality of…
View more
Author(s):
Covadonga Fernández-Golfín
,
Jose Luis Zamorano
Added:
3 years ago
Since the introduction in the early 1980s of magnetic resonance imaging (MRI) in clinical practice, contrast agents (CAs) have been part of MR studies enhancing the capabilities of this diagnostic technique. CAs enhance the contrast between different types of tissues. Tissue contrast depends largely on proton concentration and longitudinal (T1) and transversal (T2) relaxation times inherent to…
View more
Author(s):
Christopher S Hayward
,
Marc Swartz
Added:
3 years ago
Heart failure is an escalating global pandemic and one of the leading causes of death and disability in the developed world. At present, the incidence of heart failure in the Western world is staggering, affecting approximately 6.5 million people in Europe and 5.8 million people in the US.1–3 Even more alarming is the notion that approximately 10 % of this population suffers from advanced heart…
View more
Author(s):
Mirvat Alasnag
Added:
1 year ago
ESC Congress 22 —In this short and practice-focused review, Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, Jeddah, SA) shares her thoughts about 3 late ESC hot trials that will have an impact on her practice as an interventionalist cardiologist.
Trials covered in detail include:
00:18: REVIVED-BCIS2:Study of Efficacy and Safety of Percutaneous Coronary Intervention (PCI) to Improve…
View more
Author(s):
Emmanuel Ako
,
Sukhjinder Nijjer
,
Abtehale Al-Hussaini
,
et al
Added:
2 years ago
Author(s):
John Anderson
,
Nicola Donnelly
Added:
3 years ago
A range of treatments have been developed for the management of cardiac arrhythmias. These include antiarrhythmic drugs, artificial pacemakers, implanted cardiac defibrillators and ablation of damaged or malfunctioning cardiac tissue. However, to allow a physician to choose the most suitable course of treatment for a patient, it is important that the correct diagnosis be made in an appropriate…
View more
Charles Simonton
Job title: Chief Medical Officer
Author
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
2 years ago
In this concise episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their analysis of the late-breaking trials that will be presented at ACC 2022.
Trials covered in detail include:
00:39: PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients…
View more